Ionis Investigative Site

Barcelona 8907

1 studies enrolling now · 7 studies all time

What they study most

Alzheimer Disease, Down Syndrome, Familial Chylomicronemia Syndrome, Geographic Atrophy, Hereditary Angioedema, Hereditary Angioedema (HAE), Hyperlipoproteinemia Type 1, Lipoprotein Lipase Deficiency, Macular Degeneration

Studies at this site

• Donidalorsen Treatment in Children With Hereditary Angioedema — Recruiting now
• Hero: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) and Pharmacodynamics (PD) of ION269 in Participants With Down Syndrome (DS) at Risk for Alzheimer's Disease (AD) — Stopped early
• A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE) — Running, not enrolling
• GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD) — Completed
• OASIS-HAE: A Study to Evaluate the Safety and Efficacy of Donidalorsen (ISIS 721744 or IONIS-PKK-LRx) in Participants With Hereditary Angioedema (HAE) — Completed
• The APPROACH Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome — Completed
• The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Chylomicronemia Syndrome — Completed